Pfiz­er's Covid-19 vac­cine cap­tures the most an­nu­al sales of any med­ical prod­uct ever — by more than $15B

As Pfiz­er now con­trols about 70% of the Covid-19 vac­cine mar­ket in the US and Eu­rope, the com­pa­ny an­nounced Tues­day a gar­gan­tu­an to­tal of $36.8 bil­lion in 2021 sales for its life-sav­ing vac­cine.

That $36.8 bil­lion num­ber de­mol­ish­es the sec­ond-place fin­ish­er for most drug/vac­cine sales in a year, which al­so came in 2021 for Ab­b­Vie, as its be­he­moth Hu­mi­ra hauled in al­most $21 bil­lion.

But un­like Hu­mi­ra, which hauled in more than $17 bil­lion on the backs of Amer­i­cans, Pfiz­er’s vac­cine saw the li­on’s share of its sales abroad, with $7.8 bil­lion in US vac­cine sales (6 out of 10 Amer­i­cans have used Pfiz­er’s vac­cine) and $29 bil­lion in in­ter­na­tion­al sales.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER